Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Nuestra historia
    • DEA Museum
    • Divisiones operativas
      • División de Aviación
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Recovery Resources
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • Ley de Libertad de Información
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Victim Witness Assistance Program Resources

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Nuestra historia
    • DEA Museum
    • Divisiones operativas
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Recovery Resources
    • Data and Statistics
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Drug Enforcement Administration

Brian D. Boyle Special Agent in Charge
New England
@DEANewEngland
Agosto 11, 2022
Contact: Kristen Carosa
Phone Number: (617) 557-2100
For Immediate Release

Stamford Men Sentenced for Trafficking Counterfeit Oxycodone Pills Containing Fentanyl Analogues

STAMFORD, Conn. - Vanessa Roberts Avery, United States Attorney for the District of Connecticut, today announced that two Stamford residents who manufactured and distributed counterfeit oxycodone pills containing fentanyl analogues were sentenced yesterday by U.S. District Judge Stefan R. Underhill in Bridgeport.  ARBER ISAKU, 32, was sentenced to 51 months of imprisonment and three years of supervised release, and VINCENT DECARO, 32, was sentenced to 48 months of imprisonment and three years of supervised release.

According to court documents and statements made in court, Isaku and Decaro purchased fentanyl analogues from suppliers in China and, working out of Decaro’s residence at 77 West Hill Circle in Stamford, pressed the drug into counterfeit oxycodone pills, which they sold to customers on dark web markets.  David Reichard, who lived for a short time at Decaro’s residence, helped Isaku and Decaro press pills and mail the pills to customers.

On April 3, 2018, a court-authorized search of Decaro’s residence revealed numerous pills containing approximately 330 grams of fentanyl and acetyl fentanyl, approximately 40 grams of fentanyl analogues in powder form, three pill presses, instructions on how to prepare the fentanyl analogue Carfentanil, a hazardous material suit, a gas/respirator-type mask, and numerous U.S. Postal mail envelopes.

At the time of the search of Decaro’s home in April 2018, Isaku and Decaro were in Europe.  On September 21, 2018, Isaku and Decaro were arrested by Albanian State Police as they were attempting to cross the border from Albania into Kosovo.  A search of an apartment in Tirana where they had been staying revealed alprazolam, fentanyl and other controlled substances; tools and dies for pressing pills, and instructions for synthesizing fentanyl.

On June 15, 2021, Decaro pleaded guilty to one count of possession with intent to distribute fentanyl analogues and, on August 6, 2021, Isaku pleaded guilty to one count of conspiracy to possess with intent to distribute, and to distribute, fentanyl analogues.  Isaku and Decaro, who are both released on bonds, are required to report to prison on September 21 and November 2, respectively.

Reichard has pleaded guilty and awaits sentencing.

This matter has been investigated by the U.S. Postal Inspection Service, Drug Enforcement Administration, Connecticut State Police and Stamford Police Department, with the assistance of the Albanian State Police.  The case is being prosecuted by Assistant U.S. Attorneys Patrick J. Doherty and Margaret M. Donovan, with the assistance of Law Student Intern Mikayla Pieksza.

U.S. Attorney Avery thanked the U.S. Department of Justice's Office of International Affairs for coordinating the extradition proceedings in this matter.

Fentanyl Oxycodone
  • Facebook
  • Twitter
  • Email

SAMHSA Behavioral Health Treatment Locator

  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Programa de Asistencia al Empleado
    • Empleador con Igualdad de Oportunidades
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Hacer Negocios
    con la DEA
    • Resumen
    • Proveedores Actuales
    • Futuros Vendedores
    • Cláusulas de Seguridad
    • Formularios de Seguridad
    • Programa de Pequeñas Empresas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
Inicio

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook Twitter LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster